IRIS
CAPODANNO, DAVIDE FRANCESCO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.650
AS - Asia 11.499
EU - Europa 10.315
SA - Sud America 2.036
AF - Africa 1.072
Continente sconosciuto - Info sul continente non disponibili 804
OC - Oceania 12
Totale 48.388
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.643
SG - Singapore 6.049
CN - Cina 3.050
RU - Federazione Russa 3.015
IE - Irlanda 1.916
UA - Ucraina 1.785
BR - Brasile 1.669
IT - Italia 1.406
VN - Vietnam 997
CA - Canada 790
FR - Francia 615
CI - Costa d'Avorio 537
SE - Svezia 371
KR - Corea 350
NG - Nigeria 292
BD - Bangladesh 250
GB - Regno Unito 216
GR - Grecia 195
IN - India 181
DE - Germania 175
NL - Olanda 135
AR - Argentina 132
HK - Hong Kong 102
MX - Messico 95
FI - Finlandia 92
IQ - Iraq 79
PL - Polonia 77
EC - Ecuador 73
CH - Svizzera 65
SN - Senegal 64
ID - Indonesia 61
AT - Austria 60
ZA - Sudafrica 58
ES - Italia 55
TR - Turchia 54
UZ - Uzbekistan 53
CO - Colombia 49
JP - Giappone 43
VE - Venezuela 41
PK - Pakistan 32
MA - Marocco 30
BE - Belgio 28
KE - Kenya 26
JM - Giamaica 25
BJ - Benin 23
CR - Costa Rica 20
MY - Malesia 20
CL - Cile 19
PE - Perù 19
JO - Giordania 18
PH - Filippine 18
PY - Paraguay 18
SA - Arabia Saudita 17
AE - Emirati Arabi Uniti 16
EU - Europa 15
HN - Honduras 15
CZ - Repubblica Ceca 14
LT - Lituania 13
BG - Bulgaria 12
IR - Iran 12
AL - Albania 11
AZ - Azerbaigian 11
EG - Egitto 11
LB - Libano 11
NP - Nepal 11
RO - Romania 10
SV - El Salvador 10
UY - Uruguay 10
NI - Nicaragua 9
TH - Thailandia 9
TN - Tunisia 9
BY - Bielorussia 8
IL - Israele 7
KZ - Kazakistan 7
RS - Serbia 7
TT - Trinidad e Tobago 7
DZ - Algeria 6
KG - Kirghizistan 6
OM - Oman 6
PR - Porto Rico 6
SI - Slovenia 6
AU - Australia 5
BH - Bahrain 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
BZ - Belize 4
ET - Etiopia 4
GT - Guatemala 4
NZ - Nuova Zelanda 4
BA - Bosnia-Erzegovina 3
GA - Gabon 3
GE - Georgia 3
HU - Ungheria 3
MD - Moldavia 3
MK - Macedonia 3
PT - Portogallo 3
QA - Qatar 3
Totale 47.553
Salva come PNG Salva come JPEG
Città #
Singapore 3.361
Dallas 3.133
Jacksonville 2.343
Santa Clara 2.103
Dublin 1.912
San Jose 1.579
Chandler 1.364
Ashburn 1.120
Moscow 1.025
Boardman 924
Houston 647
Nanjing 637
Abidjan 537
Lawrence 534
Andover 529
Cambridge 528
Council Bluffs 519
Toronto 513
Lauterbourg 509
Chicago 452
Hefei 424
Catania 405
Des Moines 373
Seoul 349
Los Angeles 311
Ho Chi Minh City 271
Beijing 242
Nanchang 227
San Mateo 226
Hanoi 223
Civitanova Marche 201
Abuja 191
Wilmington 187
Hebei 172
New York 158
São Paulo 158
Shenyang 151
Dong Ket 141
Athens 139
Ottawa 136
Buffalo 130
Jiaxing 115
Tianjin 113
Saint Petersburg 112
Milan 89
Changsha 88
Hong Kong 86
Lagos 86
Amsterdam 83
Brooklyn 68
Rome 68
Dakar 64
Lappeenranta 64
Orem 64
Washington 62
Warsaw 57
Montreal 56
Phoenix 55
Atlanta 54
Seattle 50
Rio de Janeiro 45
Da Nang 43
Denver 42
Norwalk 42
Bremen 41
Hangzhou 40
Boston 39
Mexico City 38
Belo Horizonte 37
San Francisco 37
Stockholm 37
Chennai 36
Redondo Beach 35
Jinan 33
Tokyo 33
Johannesburg 32
Kunming 32
Pune 31
Curitiba 30
Frankfurt am Main 30
San Giovanni la Punta 30
Haiphong 29
Ningbo 29
London 28
Columbus 27
Palermo 27
Porto Alegre 27
Brasília 26
Brussels 26
Helsinki 26
Baghdad 25
Charlotte 24
Den Haag 24
Dhaka 24
Guayaquil 24
The Dalles 24
Zhengzhou 24
Cotonou 23
Liberty Lake 23
Naples 23
Totale 31.764
Salva come PNG Salva come JPEG
Nome #
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients 563
Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold 258
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds versus Everolimus-Eluting Stents: a Propensity Matched Comparison of the GHOST-EU and XIENCE V USA Registries 232
Management of myocardial revascularisation failure: an expert consensus document of the EAPCI 220
A Risk Model for Prediction of One-Year Mortality in Patients Undergoing MitraClip Implantation 191
Incorporating glomerular filtration rate or creatinine clearance by the modification of diet in renal disease equation or the Cockcroft-Gault equations to improve the global accuracy of the Age, Creatinine, Ejection Fraction [ACEF] score in patients undergoing percutaneous coronary intervention 184
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes 177
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice 172
Optimized Screening of Coronary Artery Disease With Invasive Coronary Angiography and Ad Hoc Percutaneous Coronary Intervention During Transcatheter Aortic Valve Replacement 170
A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score 169
Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke : JACC State-of-the-Art Review 167
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2 167
[Management of severe stenosis controversies and promises] 162
Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography in the Guidance of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis. 150
A focused update on emerging prognostic determinants in distal left main percutaneous coronary intervention 149
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 149
Pharmacological and Clinical Appraisal of Factor XI Inhibitor Drugs. 148
A novel 3-d reconstruction system for the assessment of bifurcation lesions treated by the mini-crush technique 148
Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry. 147
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 147
A comparison between Endeavor and Endeavor Resolute drug-eluting stents: outcome at six months follow up 144
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement. 144
Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients 140
Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity. 139
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 138
Acute Left Atrial Spontaneous Echo Contrast and Suspicious Thrombus Formation Following Mitral Regurgitation Reduction With The MitraClip System 137
A comparison between Endeavor and Endeavor Resolute drug-eluting coronary stents: outcomes at six month follow up 137
Incidence of Long-Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement 137
A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in Left Main Patients with Intermediate Global Risk 136
A Multidisciplinary Consensus Document on Follow-up Strategies for Patients Treated with Percutaneous Coronary Intervention 135
Assessment of Noninferiority Margins in Cardiovascular Medicine Trials 134
Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation. 134
2021 ESC/EACTS Guidelines for the management of valvular heart disease 134
SYNTAX Score II predicts carotid disease in a multivessel coronary disease population 132
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 129
Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair 126
Antithrombotic Therapy in Patients with Chronic Kidney Disease 125
The treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds 125
Prevention of Acute Kidney Injury with the RenalGuard System in patients undergoing Transcatheter Aortic Valve Implantation: The PROTECT-TAVI trial 125
Prevalence of renal artery stenosis in patients undergoing cardiac catheterization 124
Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric Struts 124
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 124
Eligibility to Intensified Antithrombotic Regimens for Secondary Prevention in Patients Who Underwent Percutaneous Coronary Intervention 122
Cigarette Smoking is Associated with a Dose-Response Effect in Clopidogrel Treated Patients with Diabetes Mellitus and Coronary Artery Disease: Results of a Pharmacodynamic Study 122
Suitability for elderly with heart disease of a QR code-based feedback of drug intake: Overcoming limitations of current medication adherence telemonitoring systems 120
Completeness, timing, and guidance of percutaneous coronary intervention for myocardial infarction and multivessel disease: a systematic review and network meta-analysis 120
Targeting Inflammation After Acute Myocardial Infarction 119
Characteristics and Impact of Randomized Trials on Drugs or Devices in Cardiovascular Medicine 118
Dual antiplatelet therapy de-escalation by discontinuation in patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis 118
The inflammatory abdominal aortic aneurysm and coronary artery disease. Case report and review 118
Long-term clinical and echocardiographic outcomes of Mitraclip therapy in patients nonresponders to cardiac resynchronization 118
Recent acquisitions and advances in the knowledge of coronary flow disturbances after percutaneous coronary intervention 117
Percutaneous mitral valve repair with the MitraClip system in the elderly: One-year outcomes from the GRASP registry 116
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 115
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score 115
Intraoperative defibrillation threshold testing durino implantable cardioverter-defibrillator insertion: Do we really need it? 114
A pairwise and network meta-analysis of anti-inflammatory strategies after myocardial infarction: the TITIAN study 113
Atrial and ventricular function in thalassemic patients with supraventricular arrhythmias 113
PCSK9 inhibitors: current status and emerging frontiers in lipid control 113
Temporal patterns of early neointimal strut coverage of the CATANIA stent compared with drug eluting stents and bare metal stent: the Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 113
A Risk-Scoring Model to Predict One-year Major Adverse Cardiac Events after Percutaneous Coronary Intervention 113
Current Management of In-Stent Restenosis 112
Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects 112
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 112
Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture 110
Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry 110
Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes 110
Early discharge in acute myocardial infarction after clinical and angiographic risk assessment 108
Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies 108
Bioresorbable vascular scaffold in patients with complex coronary artery disease. 108
Feasibility and Predictors of Early Discharge After Percutaneous Edge-to-Edge Mitral Valve Repair 108
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. 107
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group 107
Association of Tricuspid Regurgitation With Clinical and Echocardiographic Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Thirty-Day and Twelve-Month Follow-up From the GRASP Registry 106
Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention: When and Which Drugs? 106
Clinical implication of different plaque distribution patterns in distal left main coronary artery 106
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. 106
Predictive Accuracy of CHA2DS2-VASc and HAS-BLED Scores In Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention And Discharged On Dual Antiplatelet Therapy 106
Antithrombotic Therapy for Secondary Prevention in Patients with Cerebrovascular Disease 105
Very Late Outcomes of Drug-Eluting Stents: The "Catch-Down" Phenomenon 105
Impact of Pentoxifylline on Platelet Function Profiles in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel 105
Association of trial characteristics with simultaneous publication and its impact on citations and mentions: a cross-sectional study 104
Does the SYNTAX score get on your nerves? Practical considerations on how and when avoiding it to maximize its usefulness with no waste of time 104
Mechanisms, Pathophysiology, and Clinical Aspects of Incomplete Stent Apposition 104
Effects of Cangrelor in Coronary Artery Disease Patients With and Without Diabetes Mellitus: An In Vitro Pharmacodynamic Investigation 104
Miocardio non compattato del ventricolo sinistro e aneurisma del setto interatriale con difetto. Associazione casuale? 103
Reply: Validity of Randomized Trials Comparing Radial Versus Femoral Access in Acute Coronary Syndrome 103
Standardised Definitions of Structural Deterioration and Valve Failure in Assessing Long-Term Durability of Transcatheter and Surgical Aortic Bioprosthetic Valves: A Consensus Statement from The European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 103
Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis: SCOPE 2 Randomized Clinical Trial 103
Spontaneous coronary artery dissection 102
Upcoming TAVI trials: rationale, design and likely impact on clinical practice 102
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery 102
Three-Dimensional Angle Assessment and Plaque Distribution Classification in Left Main Disease: Impact of Geometry on Outcome 102
The year in cardiology 2017: coronary interventions 102
Operator volume and mortality in percutaneous coronary intervention: a call for better competency metrics 102
Transcatheter aortic valve implantation in 2017: state of the art 102
Diabetes mellitus: the scary killer haunting silently 101
EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention 101
Risk stratification for secondary prevention with ticagrelor and aspirin: a closer look to patient subsets from the PEGASUS-TIMI 54 trial 101
Current Status and Clinical Development of Transcatheter Approaches for Severe Mitral Regurgitation 100
Totale 13.112
Salva come PNG Salva come JPEG
Categoria #
all - tutte 178.724
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 178.724
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.682 0 0 11 50 617 12 557 99 330 5 83 918
2022/20235.175 544 67 40 349 671 984 9 813 1.430 34 172 62
2023/20242.391 125 494 111 191 100 372 50 104 17 79 472 276
2024/20258.365 96 1.244 605 325 1.997 674 153 360 706 965 448 792
2025/202618.774 1.039 914 3.395 1.185 3.132 3.248 2.714 460 898 727 630 432
2026/20271.587 692 871 24 0 0 0 0 0 0 0 0 0
Totale 48.388